Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Kaufman

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2010
Course of relapsing-remitting multiple sclerosis before, during and after natalizumabMichael D Kaufman, R Lee, H J Norton
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 2, 2026
Letter to the editor: Reconsidering fibrinolytic assessment and hemostatic management in liver transplantationRyan Nazemian, Florian Hackl, Arun Uthayashankar, et al.
Anesthesia and Analgesia|December 22, 2009
Double-lumen tubes: which lumen for the gum elastic bougie?Michael S Stix, Sana Ata, Marten Wolckenhaar, et al.
American Journal of Physical Medicine & Rehabilitation|July 23, 2003
Multiple sclerosis: severity and progression rate in African Americans compared with whitesMichael D Kaufman, Susan K Johnson, David Moyer, et al.
Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses|December 11, 2007
Adherence to therapy: using an evidence-based protocolLinda A Moore, Michael D Kaufman, Robert Algozzine, et al.
Obesity (Silver Spring, Md.)|April 28, 2009
Update on best practice recommendations for anesthetic perioperative care and pain management in weight loss surgery, 2004-2007Roman Schumann, Stephanie B Jones, Bronwyn Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinaseNoel A Powell, Jennifer K Hoffman, Fred L Ciske, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2022
Discovery of vimseltinib (DCC-3014), a highly selective CSF1R switch-control kinase inhibitor, in clinical development for the treatment of Tenosynovial Giant Cell Tumor (TGCT)Timothy M Caldwell, Yu Mi Ahn, Stacie L Bulfer, et al.
Molecular Cancer Therapeutics|August 26, 2021
Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by MacrophagesBryan D Smith, Michael D Kaufman, Scott C Wise, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2022
Discovery of acyl ureas as highly selective small molecule CSF1R kinase inhibitorsTimothy M Caldwell, Michael D Kaufman, Scott C Wise, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 8, 2010
Course of relapsing-remitting multiple sclerosis before, during and after natalizumabMichael D Kaufman, R Lee, H J Norton
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 2, 2026
Letter to the editor: Reconsidering fibrinolytic assessment and hemostatic management in liver transplantationRyan Nazemian, Florian Hackl, Arun Uthayashankar, et al.
Anesthesia and Analgesia|December 22, 2009
Double-lumen tubes: which lumen for the gum elastic bougie?Michael S Stix, Sana Ata, Marten Wolckenhaar, et al.
American Journal of Physical Medicine & Rehabilitation|July 23, 2003
Multiple sclerosis: severity and progression rate in African Americans compared with whitesMichael D Kaufman, Susan K Johnson, David Moyer, et al.
Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses|December 11, 2007
Adherence to therapy: using an evidence-based protocolLinda A Moore, Michael D Kaufman, Robert Algozzine, et al.
Obesity (Silver Spring, Md.)|April 28, 2009
Update on best practice recommendations for anesthetic perioperative care and pain management in weight loss surgery, 2004-2007Roman Schumann, Stephanie B Jones, Bronwyn Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|January 15, 2013
Highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinaseNoel A Powell, Jennifer K Hoffman, Fred L Ciske, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2022
Discovery of vimseltinib (DCC-3014), a highly selective CSF1R switch-control kinase inhibitor, in clinical development for the treatment of Tenosynovial Giant Cell Tumor (TGCT)Timothy M Caldwell, Yu Mi Ahn, Stacie L Bulfer, et al.
Molecular Cancer Therapeutics|August 26, 2021
Vimseltinib: A Precision CSF1R Therapy for Tenosynovial Giant Cell Tumors and Diseases Promoted by MacrophagesBryan D Smith, Michael D Kaufman, Scott C Wise, et al.
Bioorganic & Medicinal Chemistry Letters|August 12, 2022
Discovery of acyl ureas as highly selective small molecule CSF1R kinase inhibitorsTimothy M Caldwell, Michael D Kaufman, Scott C Wise, et al.
Pageof 2